Join 7,195 other subscribers
Tag Archives: drug pricing
Guest Blogspot – The UK Needs More Biotechnology Companies
The success of US biotechnology companies contrasts sharply with the disappointment in other countries. British companies valued by stock markets at more than about US $ 4 billion go in the FTSE 100 index. There are no biotechnology companies big … Continue reading
Posted in Business, Drugs, Emerging technologies, Finance, Genetics, Pharma, Policy, Research, Technology Tagged 2020health, Amgen, biotechnology, biotechnology company, block-buster, blockbuster, BTG, drug pricing, Genentech, genetics, medicine, Nobel Prize, patent box, pharmaceutical, pricing, R&D, R&D tax credit, Research, value-based, value-based pricing 1 Comment
Guest BlogSpot – Which Drugs are the Most Innovative?
Andrew Lansley has recently said: “I am determined that not only will we have a reimbursement price for medicines which reflects their benefit to patients, but also one which incentivises for innovation, and supports those new medicines which respond to … Continue reading
Posted in Andrew Lansley, Department of Health, Drugs, Emerging technologies, NHS, Policy, Research, Technology, Uncategorized Tagged 2020health, breakthrough, Department of Health, drug pricing, Drugs, health, innovation, innovative, medicine, outcomes, patient, pharmaceutical, R & D, reimbursement, Research, unmet clinical need, unmet healthcare need, value-based pricing Leave a comment